百日咳重现下MRBp感染的治疗、防控及面临的挑战

Treatment,Prevention and Challenges of MRBp Infection in the Resurgence of Pertussis

百日咳(whooping cough)是由百日咳鲍特菌(Bordetella pertussis,Bp)感染,通过空气传播的急性呼吸道传染病。大环内酯类抗生素(Macrolides antibiotics)一直是治疗百日咳的首选药物。但自从国内首次报道耐大环内酯类百日咳鲍特菌(Macrolide-resistant Bordetella pertussis,MRBp)后,近年来我国出现了MRBp的广泛流行。尤其近期全球百日咳重现,深入了解MRBp流性特征、诊疗、防控进展及面临的挑战尤为重要。

Whooping cough,caused by Bordetella pertussis(Bp)infection,is an acute respiratory infectious disease in children transmitted through the air.Macrolide antibiotics have long been the first-line treatment for whooping cough.However,in recent years,macrolide-resistant Bordetella pertussis(MRBp)has been rarely reported outside China.The high prevalence of MRBp in China adds to the global challenge of whooping cough resurgence.The research firstly reports the emergence of clinical MRBp strains in China and has conducted extensive research in this field.This paper focuses on discussing the progress and challenges in the diagnosis,treatment and prevention of MRBp based on historical and recent studies.